🧵 3. Following share buyback approval and Q4 results, Dabur forecasts 8% rural sales growth for FY25. Expectations high for oral care and home care segments.
You are viewing a single comment's thread from:
🧵 3. Following share buyback approval and Q4 results, Dabur forecasts 8% rural sales growth for FY25. Expectations high for oral care and home care segments.